论文部分内容阅读
目的:研究小儿肺热咳喘颗粒治疗上呼吸道感染的临床意义。方法:选择2015年7月-2016年1月本院所收治的60例上呼吸道感染患儿为临床研究对象,将患儿分为两组,对照组进行常规治疗,以此为基础,观察组服用小儿肺热咳喘颗粒进行治疗,病程结束后,对患儿的治疗结果与各临床症状消失所用时间进行全面评价。结果:与对照组相比,观察组患儿在治疗有效率与临床症状消失时长两方面,均有较好效果,组间数据存在统计学差异,P<0.05。结论:对于上呼吸道感染的患儿,以常规治疗作为基础,加小儿肺热咳喘颗粒进行治疗,安全性增高,临床效果好,值得临床推广使用。
Objective: To study the clinical significance of pediatric Feirecukechuan granule in the treatment of upper respiratory tract infection. Methods: From July 2015 to January 2016, 60 children with upper respiratory tract infection admitted to our hospital were selected as the clinical study subjects. The children were divided into two groups and the control group was treated routinely. Based on this, the observation group Taking Hyperactivity cough particles in children for treatment, after the end of the course, the treatment of children and the clinical symptoms disappeared with a comprehensive evaluation of the time. Results: Compared with the control group, the children in the observation group had good effect both in the treatment efficiency and the disappearance of the clinical symptoms. There was a significant difference between the two groups (P <0.05). Conclusion: For children with upper respiratory tract infection, based on routine treatment, children Hyperactivity-Kechuan Granule should be treated with high safety and clinical efficacy, which is worthy of clinical promotion.